Market capitalization | $9.78b |
Enterprise Value | $13.11b |
P/E (TTM) P/E ratio | 24.76 |
EV/FCF (TTM) EV/FCF | 63.41 |
EV/Sales (TTM) EV/Sales | 2.59 |
P/S ratio (TTM) P/S ratio | 1.93 |
P/B ratio (TTM) P/B ratio | 5.32 |
Dividend yield | 0.62% |
Last dividend (FY23) | $0.60 |
As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.
13 Analysts have issued a Encompass Health Corporation forecast:
13 Analysts have issued a Encompass Health Corporation forecast:
Jun '24 |
+/-
%
|
||
Revenue | 5,071 5,071 |
11%
11%
|
|
Gross Profit | 996 996 |
14%
14%
|
|
EBITDA | 1,073 1,073 |
13%
13%
|
EBIT (Operating Income) EBIT | 792 792 |
15%
15%
|
Net Profit | 398 398 |
28%
28%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Encompass Health Corp. engages in providing post-acute healthcare services. It operates through the following segments: Inpatient Rehabilitation and Home Health & Hospice. The Inpatient Rehabilitation segment operates inpatient rehabilitation hospitals that provides rehabilitative treatment and care to patients who are recovering from stroke and other neurological disorders, cardiac & pulmonary conditions, brain & spinal cord injuries, complex orthopedic conditions and amputations. The Home Health and Hospice segment provides Medicare-certified home nursing, specialized home care and in-home services. The company was founded by Richard M. Scrushy on February 22, 1984 and is headquartered in Birmingham, AL.
Head office | United States |
CEO | Mark Tarr |
Employees | 37,761 |
Founded | 1984 |
Website | www.encompasshealth.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.